220 related articles for article (PubMed ID: 12468044)
1. Striatal 6-hydroxydopamine induces apoptosis of nigral neurons in the adult rat.
Martí MJ; Saura J; Burke RE; Jackson-Lewis V; Jiménez A; Bonastre M; Tolosa E
Brain Res; 2002 Dec; 958(1):185-91. PubMed ID: 12468044
[TBL] [Abstract][Full Text] [Related]
2. NF-kappaB contributes to 6-hydroxydopamine-induced apoptosis of nigral dopaminergic neurons through p53.
Liang ZQ; Li YL; Zhao XL; Han R; Wang XX; Wang Y; Chase TN; Bennett MC; Qin ZH
Brain Res; 2007 May; 1145():190-203. PubMed ID: 17368433
[TBL] [Abstract][Full Text] [Related]
3. Treadmill exercise suppresses nigrostriatal dopaminergic neuronal loss in 6-hydroxydopamine-induced Parkinson's rats.
Yoon MC; Shin MS; Kim TS; Kim BK; Ko IG; Sung YH; Kim SE; Lee HH; Kim YP; Kim CJ
Neurosci Lett; 2007 Aug; 423(1):12-7. PubMed ID: 17644250
[TBL] [Abstract][Full Text] [Related]
4. NAIP protects the nigrostriatal dopamine pathway in an intrastriatal 6-OHDA rat model of Parkinson's disease.
Crocker SJ; Wigle N; Liston P; Thompson CS; Lee CJ; Xu D; Roy S; Nicholson DW; Park DS; MacKenzie A; Korneluk RG; Robertson GS
Eur J Neurosci; 2001 Jul; 14(2):391-400. PubMed ID: 11553289
[TBL] [Abstract][Full Text] [Related]
5. Regulation of GAP-43 protein and mRNA in nigrostriatal dopaminergic neurons after the partial destruction of dopaminergic terminals with intrastriatal 6-hydroxydopamine.
Iwata SI; Nomoto M; Fukuda T
Synapse; 2001 Jan; 39(1):16-22. PubMed ID: 11071705
[TBL] [Abstract][Full Text] [Related]
6. Alterations in the cellular distribution of bcl-2, bcl-x and bax in the adult rat substantia nigra following striatal 6-hydroxydopamine lesions.
Kramer BC; Mytilineou C
J Neurocytol; 2004 Mar; 33(2):213-23. PubMed ID: 15322379
[TBL] [Abstract][Full Text] [Related]
7. 6-Hydroxydopamine induced apoptosis of dopaminergic cells in the rat substantia nigra.
He Y; Lee T; Leong SK
Brain Res; 2000 Mar; 858(1):163-6. PubMed ID: 10700609
[TBL] [Abstract][Full Text] [Related]
8. Time-course of nigrostriatal neurodegeneration and neuroinflammation in the 6-hydroxydopamine-induced axonal and terminal lesion models of Parkinson's disease in the rat.
Walsh S; Finn DP; Dowd E
Neuroscience; 2011 Feb; 175():251-61. PubMed ID: 21145947
[TBL] [Abstract][Full Text] [Related]
9. On the altered expression of tyrosine hydroxylase and calbindin-D 28kD immunoreactivities and viability of neurons in the ventral tegmental area of Tsai following injections of 6-hydroxydopamine in the medial forebrain bundle in the rat.
Tan Y; Williams EA; Lancia AJ; Zahm DS
Brain Res; 2000 Jun; 869(1-2):56-68. PubMed ID: 10865059
[TBL] [Abstract][Full Text] [Related]
10. Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease.
Hansen HH; Fabricius K; Barkholt P; Mikkelsen JD; Jelsing J; Pyke C; Knudsen LB; Vrang N
Brain Res; 2016 Sep; 1646():354-365. PubMed ID: 27233809
[TBL] [Abstract][Full Text] [Related]
11. Pramipexole attenuates the dopaminergic cell loss induced by intraventricular 6-hydroxydopamine.
Vu TQ; Ling ZD; Ma SY; Robie HC; Tong CW; Chen EY; Lipton JW; Carvey PM
J Neural Transm (Vienna); 2000; 107(2):159-76. PubMed ID: 10847557
[TBL] [Abstract][Full Text] [Related]
12. Intranigral infusion of interleukin-1beta activates astrocytes and protects from subsequent 6-hydroxydopamine neurotoxicity.
Saura J; Parés M; Bové J; Pezzi S; Alberch J; Marin C; Tolosa E; Martí MJ
J Neurochem; 2003 May; 85(3):651-61. PubMed ID: 12694391
[TBL] [Abstract][Full Text] [Related]
13. Tissue distribution and neuroprotective effects of citrus flavonoid tangeretin in a rat model of Parkinson's disease.
Datla KP; Christidou M; Widmer WW; Rooprai HK; Dexter DT
Neuroreport; 2001 Dec; 12(17):3871-5. PubMed ID: 11726811
[TBL] [Abstract][Full Text] [Related]
14. Effect of unilateral lesion of the nigrostriatal dopamine pathway on survival and neurochemistry of parafascicular nucleus neurons in the rat--evaluation of time-course and LGR8 expression.
Sedaghat K; Finkelstein DI; Gundlach AL
Brain Res; 2009 May; 1271():83-94. PubMed ID: 19328193
[TBL] [Abstract][Full Text] [Related]
15. Time course of degenerative alterations in nigral dopaminergic neurons following a 6-hydroxydopamine lesion.
Zuch CL; Nordstroem VK; Briedrick LA; Hoernig GR; Granholm AC; Bickford PC
J Comp Neurol; 2000 Nov; 427(3):440-54. PubMed ID: 11054705
[TBL] [Abstract][Full Text] [Related]
16. Identification and kainic acid-induced up-regulation of low-affinity p75 neurotrophin receptor (p75NTR) in the nigral dopamine neurons of adult rats.
Wang YQ; Bian GL; Bai Y; Cao R; Chen LW
Neurochem Int; 2008 Sep; 53(3-4):56-62. PubMed ID: 18639597
[TBL] [Abstract][Full Text] [Related]
17. The stepping test and its learning process in different degrees of unilateral striatal lesions by 6-hydroxydopamine in rats.
Fang X; Sugiyama K; Akamine S; Namba H
Neurosci Res; 2006 Aug; 55(4):403-9. PubMed ID: 16730826
[TBL] [Abstract][Full Text] [Related]
18. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections.
Kozlowski DA; Connor B; Tillerson JL; Schallert T; Bohn MC
Exp Neurol; 2000 Nov; 166(1):1-15. PubMed ID: 11031079
[TBL] [Abstract][Full Text] [Related]
19. Reduction in parvalbumin expression in the zona incerta after 6OHDA lesion in rats.
Heise CE; Mitrofanis J
J Neurocytol; 2005 Dec; 34(6):421-34. PubMed ID: 16902763
[TBL] [Abstract][Full Text] [Related]
20. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease.
Oiwa Y; Yoshimura R; Nakai K; Itakura T
Brain Res; 2002 Aug; 947(2):271-83. PubMed ID: 12176170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
